Refine by
Blood Transfusion Technology
4 companies found
Technologybased inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
With support from a National Institutes of Health grant, Kephera is developing a new point-of-care test for Chagas disease. Kephera scientists have identified and are purifying parasite components which promise to yield a highly sensitive and ...
Technologybased inMandello del Lario, ITALY
Founded in 1947 by Dr. Ing. Arturo Gilardoni, the company has established itself as a pioneer in the development and innovation of X-ray technology. Initially focused on X-ray tubes, Gilardoni has broadened its scope to include a range of advanced ...
The RADGIL2 is a specialized X-Ray irradiator designed to mitigate Transfusion Associated-Graft versus Host Disease (TA-GvHD), a rare but potentially lethal immune reaction that occurs when donor T-lymphocytes attack tissues in a transfusion ...
Technologybased inPasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
Pre-clinical studies showed that LB-100 alone inhibits a spectrum of human cancers but when combined with standard cytotoxic drugs and/or radiation, LB-100 potentiates their effectiveness against hematologic and solid tumor cancers without enhancing ...
Technologybased inCastel Maggiore (BO), ITALY
Rejoint is a company founded in 2015. Pioneer in new technology and surgical approaches in Total Knee Arthroplasty. Rejoint has developed a solution for knee replacement based on the integration of 3D Additive Manufacturing (AM), Artificial ...
Over 25% of your TKA patients are dissatisfied about their treatment outcomes and you spend time and money to manage surgeries and ...